PET/MRI: Where might it replace PET/CT?

Simultaneous positron emission tomography and MRI (PET/MRI) is a technology that combines the anatomic and quantitative strengths of MR imaging with physiologic information obtained from PET. PET and computed tomography (PET/CT) performed in a single scanning session is an established technology already in widespread and accepted use worldwide. Given the higher cost and complexity of operating and interpreting the studies obtained on a PET/MRI system, there has been question as to which patients would benefit most from imaging with PET/MRI versus PET/CT. In this article, we compare PET/MRI with PET/CT, detail the applications for which PET/MRI has shown promise and discuss impediments to future adoption. It is our hope that future work will prove the benefit of PET/MRI to specific groups of patients, initially those in which PET/CT and MRI are already performed, leveraging simultaneity and allowing for greater degrees of multiparametric evaluation.

[1]  Andrew P. Leynes,et al.  Hybrid ZTE/Dixon MR‐based attenuation correction for quantitative uptake estimation of pelvic lesions in PET/MRI , 2017, Medical physics.

[2]  K. Hergan,et al.  Erratum to: Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series , 2017, Journal of Nuclear Cardiology.

[3]  O. Akin,et al.  Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma , 2017, Clinical nuclear medicine.

[4]  K. Hergan,et al.  Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series , 2018, Journal of Nuclear Cardiology.

[5]  G. Antoch,et al.  Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer – does it change therapeutic decisions in comparison to 18F-FDG PET/CT? , 2017, European Radiology.

[6]  Michael Forsting,et al.  Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT. , 2016, European journal of radiology.

[7]  M. Schwaiger,et al.  Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer. , 2016, European urology.

[8]  O. Sabri,et al.  Simultaneous (18)F-FDG-PET/MRI: Associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma. , 2016, Oral oncology.

[9]  A. Buck,et al.  Clinical Evaluation of Zero-Echo-Time Attenuation Correction for Brain 18F-FDG PET/MRI: Comparison with Atlas Attenuation Correction , 2016, The Journal of Nuclear Medicine.

[10]  A. Wetter,et al.  Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI , 2016, PloS one.

[11]  Yi Su,et al.  Impact of MR-Based Attenuation Correction on Neurologic PET Studies , 2016, The Journal of Nuclear Medicine.

[12]  B. Bijan,et al.  Comparison of different functional imaging modalities including FDG PET/CT and DWI-MRI with respect to their value in TNM staging of cholangiocarcinoma. , 2016 .

[13]  Sirong Chen,et al.  Response prediction in HCC patients treated with 90Y glass microspheres based on metabolic parameters: post-radioembolization 90Y PET/CT tumor dose and pretreatment 11C-acetate & 18F-FDG PET/CT metobolic grading , 2016 .

[14]  A. Wetter,et al.  Comparative Performance of 18F-FDG PET/MRI and 18F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients , 2016, The Journal of Nuclear Medicine.

[15]  R. Laforest,et al.  Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma , 2016, Pediatric Radiology.

[16]  Gaspar Delso,et al.  Design Features and Mutual Compatibility Studies of the Time-of-Flight PET Capable GE SIGNA PET/MR System , 2016, IEEE Transactions on Medical Imaging.

[17]  C. Dodge,et al.  Assessment of Sequential PET/MRI in Comparison With PET/CT of Pediatric Lymphoma: A Prospective Study. , 2016, AJR. American journal of roentgenology.

[18]  Tyler J. Fraum,et al.  PET/MRI: Emerging Clinical Applications in Oncology. , 2016, Academic radiology.

[19]  A. Buck,et al.  Evaluation of Atlas-Based Attenuation Correction for Integrated PET/MR in Human Brain: Application of a Head Atlas and Comparison to True CT-Based Attenuation Correction , 2016, Journal of Nuclear Medicine.

[20]  B. Rosen,et al.  Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients , 2016, Abdominal Radiology.

[21]  G. Delso,et al.  Zero TE MR bone imaging in the head , 2016, Magnetic resonance in medicine.

[22]  N. Schwenzer,et al.  Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to 18F-Fluorodeoxyglucose Positron Emission Tomography/Compu , 2016, Investigative radiology.

[23]  G. V. von Schulthess,et al.  TNM Staging of Non–Small Cell Lung Cancer: Comparison of PET/MR and PET/CT , 2016, The Journal of Nuclear Medicine.

[24]  Gerald Antoch,et al.  Evaluation of the Outcome of Lung Nodules Missed on 18F-FDG PET/MRI Compared with 18F-FDG PET/CT in Patients with Known Malignancies , 2016, The Journal of Nuclear Medicine.

[25]  J. Lee,et al.  Added Value of Integrated Whole-Body PET/MRI for Evaluation of Colorectal Cancer: Comparison With Contrast-Enhanced MDCT. , 2016, AJR. American journal of roentgenology.

[26]  C. Tzavara,et al.  Incremental prognostic value of MRI in the staging of early cervical cancer: a prospective study and review of the literature. , 2016, Clinical imaging.

[27]  Kevin M. Johnson,et al.  Detection of Small Pulmonary Nodules with Ultrashort Echo Time Sequences in Oncology Patients by Using a PET/MR System. , 2016, Radiology.

[28]  C. Levin,et al.  Design Features and Mutual Compatibility Studies of the Time-of-Flight PET Capable GE SIGNA PET/MR System. , 2016, IEEE transactions on medical imaging.

[29]  B. Sheu,et al.  Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole‐body PET/MR: Correlation with pathological prognostic factors , 2015, Journal of magnetic resonance imaging : JMRI.

[30]  Peter B Sachs,et al.  Lung CT Screening Reporting and Data System Speed and Accuracy Are Increased With the Use of a Semiautomated Computer Application. , 2015, Journal of the American College of Radiology : JACR.

[31]  Michael Forsting,et al.  Implementation of FAST-PET/MRI for whole-body staging of female patients with recurrent pelvic malignancies: A comparison to PET/CT. , 2015, European journal of radiology.

[32]  H. Goldschmidt,et al.  Comparison of (18)F-FDG PET/CT and PET/MRI in patients with multiple myeloma. , 2015, American journal of nuclear medicine and molecular imaging.

[33]  M. Forsting,et al.  Integrated PET/MRI for whole-body staging of patients with primary cervical cancer: preliminary results , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  H. Quick,et al.  Oncological whole-body staging in integrated (18)F-FDG PET/MR: Value of different MR sequences for simultaneous PET and MR reading. , 2015, European journal of radiology.

[35]  G. Hermosillo,et al.  Whole-Body PET/MR Imaging: Quantitative Evaluation of a Novel Model-Based MR Attenuation Correction Method Including Bone , 2015, The Journal of Nuclear Medicine.

[36]  A. Scarsbrook,et al.  FDG PET/CT in infection and inflammation--current and emerging clinical applications. , 2015, Clinical radiology.

[37]  Yasheng Chen,et al.  MR-based attenuation correction for PET/MRI neurological studies with continuous-valued attenuation coefficients for bone through a conversion from R2* to CT-Hounsfield units , 2015, NeuroImage.

[38]  S. Hain,et al.  Value of Gallium-68 Dotatate PET Scan in staging patients with appendiceal carcinoid tumour: a case series. , 2015 .

[39]  K. Yaddanapudi,et al.  PET-MRI in diagnosing pedal osteomyelitis in diabetic patients , 2015 .

[40]  H. Zaidi,et al.  Impact of Time-of-Flight PET on Quantification Errors in MR Imaging–Based Attenuation Correction , 2015, The Journal of Nuclear Medicine.

[41]  H. Chandarana,et al.  PET/MRI for the evaluation of patients with lymphoma: initial observations. , 2015, AJR. American journal of roentgenology.

[42]  S. Matsumoto,et al.  Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients. , 2015, Radiology.

[43]  Garry Gold,et al.  Simultaneous Whole-Body Time-of-Flight 18F-FDG PET/MRI: A Pilot Study Comparing SUVmax With PET/CT and Assessment of MR Image Quality , 2015, Clinical nuclear medicine.

[44]  P. Christian,et al.  Quantitative PET/CT Scanner Performance Characterization Based Upon the Society of Nuclear Medicine and Molecular Imaging Clinical Trials Network Oncology Clinical Simulator Phantom , 2015, The Journal of Nuclear Medicine.

[45]  M. Essler,et al.  Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[46]  M. Roethke,et al.  Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[47]  Gerald Antoch,et al.  Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[48]  Koichi Nagata,et al.  Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT. , 2014, World journal of gastroenterology.

[49]  D. Jeyarajah,et al.  MRI with Gadoxetate Disodium for Colorectal Liver Metastasis: Is It the New “Imaging Modality of Choice”? , 2014, Journal of Gastrointestinal Surgery.

[50]  Felix Nensa,et al.  Clinical applications of PET/MRI: current status and future perspectives. , 2014, Diagnostic and interventional radiology.

[51]  Jaap Stoker,et al.  Whole‐body MRI, including diffusion‐weighted imaging, for staging lymphoma: Comparison with CT in a prospective multicenter study , 2014, Journal of magnetic resonance imaging : JMRI.

[52]  O. Sabri,et al.  Potential Pediatric Applications of PET/MR , 2014, The Journal of Nuclear Medicine.

[53]  M. Forsting,et al.  Correlation of Standardized Uptake Value and Apparent Diffusion Coefficient in Integrated Whole-Body PET/MRI of Primary and Recurrent Cervical Cancer , 2014, PloS one.

[54]  P. Heusch,et al.  Thoracic Staging in Lung Cancer: Prospective Comparison of 18F-FDG PET/MR Imaging and 18F-FDG PET/CT , 2014, The Journal of Nuclear Medicine.

[55]  F. Bengel,et al.  Advanced Imaging of Cardiac Sarcoidosis , 2014, The Journal of Nuclear Medicine.

[56]  M. Forsting,et al.  [18F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[57]  G. Cheon,et al.  Usefulness of Integrated PET/MRI in Head and Neck Cancer: A Preliminary Study , 2013, Nuclear Medicine and Molecular Imaging.

[58]  C. Geppert,et al.  Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI. , 2013, AJR. American journal of roentgenology.

[59]  T. Holland-Letz,et al.  Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[60]  C. Geppert,et al.  Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET/MR and PET/CT imaging. , 2013, Radiology.

[61]  R. Dierckx,et al.  The Use of 18F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases , 2013, Clinical & developmental immunology.

[62]  J. Vercher-Conejero,et al.  PET/MRI: Applications in Clinical Imaging , 2013, Current Radiology Reports.

[63]  Torsten Kuwert,et al.  Systematic Evaluation of Phantom Fluids for Simultaneous PET/MR Hybrid Imaging , 2013, The Journal of Nuclear Medicine.

[64]  M. Forsting,et al.  Correlation of the Apparent Diffusion Coefficient (ADC) with the Standardized Uptake Value (SUV) in Hybrid 18F-FDG PET/MRI in Non-Small Cell Lung Cancer (NSCLC) Lesions: Initial Results , 2013, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[65]  A. Haug,et al.  68Ga-DOTATATE PET/CT in the pre-surgical staging of ileal and pancreatic neuroendocrine tumors: Correlation with histopathology and impact on surgical management , 2013 .

[66]  C. Claussen,et al.  Correlation of Simultaneously Acquired Diffusion-Weighted Imaging and 2-Deoxy-[18F] fluoro-2-D-glucose Positron Emission Tomography of Pulmonary Lesions in a Dedicated Whole-Body Magnetic Resonance/Positron Emission Tomography System , 2013, Investigative radiology.

[67]  A. Alavi,et al.  PET/MR imaging: technical aspects and potential clinical applications. , 2013, Radiology.

[68]  H. Jadvar Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[69]  Sheung Tat Fan,et al.  11C-Acetate and 18F-FDG PET/CT for Clinical Staging and Selection of Patients with Hepatocellular Carcinoma for Liver Transplantation on the Basis of Milan Criteria: Surgeon’s Perspective , 2013, The Journal of Nuclear Medicine.

[70]  Colin Studholme,et al.  Interictal PET and ictal subtraction SPECT: Sensitivity in the detection of seizure foci in patients with medically intractable epilepsy , 2013, Epilepsia.

[71]  T. Holland-Letz,et al.  PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[72]  T. Derlin,et al.  Comparative diagnostic performance of 18F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation , 2013, European Radiology.

[73]  E. Zamagni,et al.  The role of imaging techniques in the management of multiple myeloma , 2012, British journal of haematology.

[74]  S. Thiruvenkadam,et al.  Comparison of 4-class and continuous fat/water methods for whole-body, MR-based PET attenuation correction , 2012, 2012 IEEE Nuclear Science Symposium and Medical Imaging Conference Record (NSS/MIC).

[75]  Michael Laniado,et al.  PET/MRI in head and neck cancer: initial experience , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[76]  H. Zhuang,et al.  PET/CT in Patients with Sarcoidosis or IgG4 Disease. , 2012, PET clinics.

[77]  G. Fink,et al.  Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[78]  Kevin Petrecca,et al.  Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma , 2012, Journal of Neuro-Oncology.

[79]  Kenji Hirata,et al.  18F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[80]  C. Boy,et al.  68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors , 2011, The Journal of Nuclear Medicine.

[81]  Gina Brown,et al.  Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  S. Majumdar,et al.  Ultrashort echo time MRI of cortical bone at 7 tesla field strength: A feasibility study , 2011, Journal of magnetic resonance imaging : JMRI.

[83]  James M. Mountz,et al.  SPECT Imaging of Epilepsy: An Overview and Comparison with F-18 FDG PET , 2011, International journal of molecular imaging.

[84]  Yousef Mazaheri,et al.  Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. , 2011, Radiology.

[85]  Alberto Pupi,et al.  PET/CT in diagnosis of dementia , 2011, Annals of the New York Academy of Sciences.

[86]  Alimuddin Zumla,et al.  Combined PET and X-ray computed tomography imaging in pulmonary infections and inflammation , 2011, Current opinion in pulmonary medicine.

[87]  T. Takahara,et al.  Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT. , 2011, AJR. American journal of roentgenology.

[88]  W. Curran,et al.  Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. , 2009, International journal of radiation oncology, biology, physics.

[89]  U. Tateishi,et al.  The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level , 2011, Annals of nuclear medicine.

[90]  Mark Bydder,et al.  Qualitative and quantitative ultrashort echo time (UTE) imaging of cortical bone. , 2010, Journal of magnetic resonance.

[91]  Jeffry S Nyman,et al.  Characterization of 1H NMR signal in human cortical bone for magnetic resonance imaging , 2010, Magnetic resonance in medicine.

[92]  Paul E Kinahan,et al.  Variability in PET quantitation within a multicenter consortium. , 2010, Medical physics.

[93]  A. Crucitti,et al.  Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. , 2010, Radiographics.

[94]  R. Tishler,et al.  Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[95]  Satoshi Goshima,et al.  Preoperative detection of prostate cancer: A comparison with 11C‐choline PET, 18F‐fluorodeoxyglucose PET and MR imaging , 2010, Journal of magnetic resonance imaging : JMRI.

[96]  T. Borght,et al.  Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma , 2010, Acta oncologica.

[97]  P. Lambin,et al.  18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation. , 2010, European journal of cancer.

[98]  J. Bruzzi,et al.  Clinical utility of PET/CT in lymphoma. , 2010, AJR. American journal of roentgenology.

[99]  M. Chamberlain Radiographic patterns of relapse in glioblastoma , 2010, Journal of Neuro-Oncology.

[100]  F. Kee,et al.  The value of positron emission tomography in patients with non-small cell lung cancer. , 2010, European journal of radiology.

[101]  Hiroki Kato,et al.  Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography , 2010, Japanese Journal of Radiology.

[102]  F. Fazio,et al.  Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: a cost-effectiveness analysis. , 2009, European journal of cancer care.

[103]  N. Ferris,et al.  Preoperative staging of rectal cancer. , 2009, Future oncology.

[104]  Martin Hutchings,et al.  PET/CT for Therapy Response Assessment in Lymphoma , 2009, Journal of Nuclear Medicine.

[105]  Pek-Lan Khong,et al.  Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. , 2009, Radiology.

[106]  Janet F. Eary,et al.  NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of 3′-Deoxy-3′-[18F]fluorothymidine (FLT) as a Marker of Proliferation in Patients with Recurrent Gliomas: Preliminary Efficacy Studies , 2009, Molecular Imaging and Biology.

[107]  S. Goldman,et al.  POSITRON EMISSION TOMOGRAPHY‐GUIDED VOLUMETRIC RESECTION OF SUPRATENTORIAL HIGH‐GRADE GLIOMAS: A SURVIVAL ANALYSIS IN 66 CONSECUTIVE PATIENTS , 2009, Neurosurgery.

[108]  T. Chen,et al.  The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma. , 2009, Academic radiology.

[109]  R Sankar,et al.  FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy , 2008, Neurology.

[110]  B. O'neill,et al.  Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. , 2007, The Lancet. Oncology.

[111]  Klemens Scheidhauer,et al.  Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[112]  P. Maisonneuve,et al.  Carcinoma of the cervix uteri , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[113]  G. Mathern,et al.  FDG‐PET/MRI Coregistration and Diffusion‐Tensor Imaging Distinguish Epileptogenic Tubers and Cortex in Patients with Tuberous Sclerosis Complex: A Preliminary Report , 2006, Epilepsia.

[114]  Wei Chen,et al.  18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[115]  P. Maisonneuve,et al.  Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[116]  Rodney J Hicks,et al.  Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[117]  F. Guillemin,et al.  Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[118]  Sibylle Ziegler,et al.  PET/CT: challenge for nuclear cardiology. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[119]  A. Bernard,et al.  Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule , 2005, The European Journal of Health Economics.

[120]  M. Mathews,et al.  Cost-Effectiveness of Positron Emission Tomography in Breast Cancer , 2005, Molecular Imaging and Biology.

[121]  D. Matchar,et al.  FDG-PET for management of cervical and ovarian cancer. , 2005, Gynecologic oncology.

[122]  A H Kaye,et al.  MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome. , 2004, Brain : a journal of neurology.

[123]  G Lucignani,et al.  The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective , 2004, Nuclear medicine communications.

[124]  S. Larson,et al.  Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. , 2004, Journal of the American College of Surgeons.

[125]  J. Tropp,et al.  Image brightening in samples of high dielectric constant. , 2004, Journal of magnetic resonance.

[126]  M. Frydenberg,et al.  Investigations with FDG-PET Scanning in Prostate Cancer Show Limited Value for Clinical Practice , 2002, Acta oncologica.

[127]  O. Dworak Morphology of lymph nodes in the resected rectum of patients with rectal carcinoma. , 1991, Pathology, research and practice.

[128]  A. Friedman,et al.  Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography , 1991, Annals of neurology.

[129]  W P Dillon,et al.  Radiation injury of the brain. , 1991, AJNR. American journal of neuroradiology.